← 治験一覧に戻る
膵臓癌の完全切除を受けた患者に対する2つの化学療法レジメンと経過観察との比較
基本情報
- NCT ID
- NCT00058201
- ステータス
- 完了
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 1,030
- 治験依頼者名
- National Cancer Institute (NCI)
概要
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which chemotherapy regimen is more effective, or whether chemotherapy is more effective than observation, in treating pancreatic cancer after surgery. PURPOSE: Phase III trial to compare the effectiveness of two chemotherapy regimens with no further therapy in treating patients who have completely resected pancreatic cancer.
対象疾患
Pancreatic Cancer
介入
fluorouracil(DRUG)
gemcitabine hydrochloride(DRUG)
leucovorin calcium(DRUG)
clinical observation(OTHER)
依頼者（Sponsor）
Ncic Clinical Trials Group(NETWORK)
Royal Liverpool University Hospital(OTHER_GOV)
実施施設 (1)
京都大学医学部附属病院
Kyoto, Kyoto, Japan